PFPfizer PFE · NYSE
$29.37 -0.71% (-$0.21)
- Market cap
- $168.5B
- Enterprise value
- $230.8B
- P/E
- 38.9x
- Forward P/E
- 10.0x
- PEG
- -
- P/S
- 2.6x
- P/FCF
- 15.3x
- EV/EBITDA
- 18.3x
- ROIC
- 9.7%
- Gross margin
- 71.3%
- Net margin
- 6.8%
- Dividend yield
- 5.82%
- Payout ratio
- 226.1%
- Net debt/EBITDA
- 4.9x
- Beta
- 0.28
- Free float
- 99.9%
About the company
Pfizer (PFE) is a global pharmaceutical company specializing in research, development, and manufacturing of medicinal products. With over 170 years of experience, Pfizer has become one of the most prominent players in the healthcare industry. Their innovative drugs and vaccines have a significant impact on people's health and quality of life worldwide. Pfizer stock is suitable for investors seeking stable and long-term growth in the pharmaceutical sector. Add PFE stock to your watchlist on Bulios and stay informed about the latest news and developments of this significant pharmaceutical company.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Albert Bourla
Employees
75,000
Headquarters
New York City
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number